Bioresorbable drug-eluting scaffolds for treatment of vascular disease
© 2016 Informa UK Limited. Introduction: Theoretical advantages of fully bioresorbable scaffold (BRS) stem from transient vessel support without rigid caging. Therefore, it could reduce long-term adverse events associated with the presence of foreign materials.Areas covered: This article will provid...
Saved in:
Main Authors: | Suwannasom P., Sotomi Y., Tateishi H., Tenekecioglu E., Zeng Y., Kraak R., Wykrzykowska J., De Winter R., Serruys P., Onuma Y. |
---|---|
格式: | 雜誌 |
出版: |
2017
|
在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84961205510&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41890 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Bioresorbable drug-eluting scaffolds for treatment of vascular disease
由: Pannipa Suwannasom, et al.
出版: (2018) -
Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: From bench to clinical use
由: Yohei Sotomi, et al.
出版: (2018) -
Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: From bench to clinical use
由: Yohei Sotomi, et al.
出版: (2018) -
Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
由: Sotomi Y., et al.
出版: (2017) -
Imaging assessment of bioresorbable vascular scaffolds
由: Yohei Sotomi, et al.
出版: (2018)